SARS-CoV-2 RBD (NB.8.1) Recombinant eiwit (C-His)

Surface glycoprotein, partial [Severe acute respiratory syndrome coronavirus 2], S, GISAID_ID: EPI_ISL_19029461, N-terminal domain of the S1 subunit of the Spike (S) protein from Severe acute respiratory syndrome coronavirus and related betacoronaviruses in the B lineage; cd21624, trimer interface [polypeptide binding], receptor-binding domain of the S1 subunit of coronavirus spike (S) proteins; cl40478, trimer interface [polypeptide binding], putative receptor binding site [polypeptide binding], receptor binding motif, S1/S2 cleavage region and the S2 fusion subunit of coronavirus spike (S) proteins; cl40439, S1/S2 cleavage region, fusion peptide, internal fusion peptide, heptad repeat 1 [structural motif]

Mammalian Cells

Recombinant

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

>90% as determined by SDS-PAGE.

Lyophilized

Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol.

RECONSTITUTION PROTOCOLNote: Do not mix by vortexing or by pipetting the material up and down.

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

For research use only

27.64 kDa

Severe acute respiratory syndrome coronavirus 2